SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-19-000007
Filing Date
2019-05-15
Accepted
2019-05-15 13:21:37
Documents
74
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20190331x10q.htm 10-Q 1386215
2 EX-10.1 veru-20190331xex10_1.htm EX-10.1 73295
3 EX-10.3 veru-20190331xex10_3.htm EX-10.3 88615
4 EX-31.1 veru-20190331xex31_1.htm EX-31.1 15627
5 EX-31.2 veru-20190331xex31_2.htm EX-31.2 15963
6 EX-32.1 veru-20190331xex32_1.htm EX-32.1 11471
  Complete submission text file 0000863894-19-000007.txt   7072676

Data Files

Seq Description Document Type Size
7 EX-101.INS veru-20190331.xml EX-101.INS 1623750
8 EX-101.SCH veru-20190331.xsd EX-101.SCH 53546
9 EX-101.CAL veru-20190331_cal.xml EX-101.CAL 53012
10 EX-101.DEF veru-20190331_def.xml EX-101.DEF 196755
11 EX-101.LAB veru-20190331_lab.xml EX-101.LAB 416620
12 EX-101.PRE veru-20190331_pre.xml EX-101.PRE 366533
Mailing Address 4400 BISCAYNE BOULEVARD SUITE 888 MIAMI FL 33137
Business Address 4400 BISCAYNE BOULEVARD STE 888 MIAMI FL 33137 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 19826792
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1